FDA

Pfizer to gradually move antibacterials operations to China

Wednesday, March 16, 2011 01:00 PM

Pfizer plans to move its antibacterials research unit in Groton, Conn., to Shanghai, China, but said some local scientists involved in the research will remain in Groton for up to two years as the company builds the new Shanghai unit, according to a report in Connecticut newspaper The Day.

More... »

Dendreon’s CSO, Dave Urdal, to retire

Tuesday, March 15, 2011 01:43 PM

David Urdal, the scientific entrepreneur who co-founded Dendreon 15 years ago and helped turn it into a pioneer of cancer immunotherapy, is stepping down from his job as chief scientific officer at the Seattle biotech company, according to Xconomy Seattle.

More... »

Adamis looks to test prostate cancer drug on humans

Monday, March 14, 2011 01:48 PM

Adamis Pharmaceuticals is seeking permission from federal regulators to begin testing APC-100, an experimental prostate cancer drug, on human patients for the first time, according to the San Diego Union-Tribune.

More... »

Lilly CEO confident in FDA approval

Monday, March 14, 2011 01:31 PM

Eli Lilly CEO John Lechleiter said he's confident of gaining U.S. regulatory approval for a drug to help identify plaque in the brain associated with Alzheimer's disease, according to a Bloomberg News report.

More... »

Report: Big Pharmas embracing technology as they transform to ‘holistic healthcare entities’

Monday, March 14, 2011 07:00 AM

Pharmaceutical companies—having outsourced R&D functions to CROs and collaborated with biotechs, drug companies and academic groups for innovative products and platforms—are now embracing a different type of innovation: technology.

More... »

Genetics remains at top of academic research

Friday, March 11, 2011 01:51 PM

Genetics is still the hottest area of scientific research, a decade since the mapping of the human genome, despite slow progress in translating discoveries into new medical treatments, according to a report in Reuters.

More... »

FDA approves generic Taxotere

Friday, March 11, 2011 01:47 PM

Hospira has won approval for the first U.S. generic version of Sanofi-aventis’ Taxotere cancer drug, according to a Reuters report.

More... »

ARYx Therapeutics to close

Friday, March 11, 2011 01:41 PM

ARYx Therapeutics said it will wind down its operations due to lack of funding after the FDA delayed providing guidance on the trial design of its experimental drug for gastrointestinal disorders, according to Reuters.

More... »

Talecris Biotherapeutics receives EU orphan drug designation for Plasmin

Friday, March 11, 2011 11:56 AM

Talecris Biotherapeutics has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by a clot. 

More... »

Teva: Doctors being contacted for trial of Copaxone copy

Wednesday, March 9, 2011 01:34 PM

Doctors are being contacted to organize a clinical trial for a copy of Teva Pharmaceutical’s multiple sclerosis medicine Copaxone, according to a report in FiercePharma.

More... »